Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Segments and Strategic Developments
NDSN logo

Nordson Corp Achieves 5% EPS Growth Amid Strategic Medical Divestitures

NDSN10-KFiling Date: 12/17/2025
Nordson Corporation
Description

What this story covers

Noah and Ash discuss Nordson’s fiscal 2025 performance, highlighting its 55% gross margins, strategic acquisitions like Atrion, and the "Ascend" strategy. They explore how the company balances global risks with robust cash flow and shareholder returns.

Story snapshot

CompanyNordson Corporation
TickerNDSN
VariantStandard detailed
Duration17:32
Filing type10-K
PeriodAnnual 2025
IndustryIndustrials & Manufacturing
Accession0000072331-25-000144
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in